This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lansang, M C. Articles by Hollenberg, N. K Search for Related Content PubMed PubMed Citation Articles by Lansang, M C. Articles by Hollenberg, N. K Social Bookmarking                         What's this?

ACE inhibition and the kidney: species variation in the mechanisms responsible for the renal haemodynamic response

Departments of Radiology and Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA

Norman K Hollenberg

Departments of Radiology and Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA

Key Words: ACE inhibition • species variation

References

• Porush JG Hypertension and chronic renal failure: the use of ACE inhibitors. Am J Kidney Dis 1998;31:177-84.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Laffel LM, McGill JB, Gans DJ The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. Am J Med 1995;99:497-504.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Parving HH, Rossing P., Hommel E. et al. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience. Am J Kidney Dis 1995;26:99-107.[Web of Science][Medline] [Order article via Infotrieve]
• The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997;349:1857-63.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ruggenenti P., Perna A., Gherardi G. et al. Renoprotective properties of ACE inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999;354:359-64.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mori M., Akatsuka N., Fukazawa M. et al. Endothelium-dependent relaxation by angiotensin converting enzyme inhibitors in canine femoral arteries. Am J Physiol 1994;266:H583-H589.[Web of Science][Medline] [Order article via Infotrieve]
• Hollenberg NK ACE inhibitors, AT1 receptor blockers, and the kidney. Nephrol Dial Transplant 1997;12:381-3.[Free Full Text]
• Hollenberg NK Corcoran Lecture: Implications of species difference for clinical investigation: studies on the renin-angiotensin system. Hypertension 2000;35:150-4.[Abstract/Free Full Text]
• Zimmerman BG, Raich PC,Vavrek RJ et al. Bradykinin contribution to renal blood flow effect of angiotensin converting enzyme inhibitor in the conscious sodium-restricted dog. Circ Res 1990;66:234(c)-240.
• Endlich K., Steinhausen M. Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels. J Hypertension 1997;15:633-41.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Heller J., Kramer HJ, Horacek V. Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog. Kidney Blood Press Res 1997;20:391-7.[Web of Science][Medline] [Order article via Infotrieve]
• Matsuda H., Hayashi K., Arakawa K. et al. Zonalheterogeneity in action of angiotensin converting enzyme inhibitor on renal microcirculation: role of intrarenal bradykinin. J Am Soc Nephrol 1999;10:2272-82.[Abstract/Free Full Text]
• Clappison BH, Anderson WP, Johnston CI Renal hemodynamics and renal kinins after angiotensin converting enzyme inhibition. Kidney International 1981;20:615-20.[Web of Science][Medline] [Order article via Infotrieve]
• Clappison BH, Anderson WP, Johnston CI Role of the kallikrein-kinin system in the renal effects of angiotensin converting enzyme inhibition in anesthetized dogs. Clin Exp Pharmacol Physiol 1981;8:509-13.[Web of Science][Medline] [Order article via Infotrieve]
• Naitoh M., Suzuki H., Arakawa K. et al. Role of kinin and renal AngII blockade in acute effects of ACE inhibitors in low-renin hypertension. Am J Physiol 1997;272:H679-H687.[Web of Science][Medline] [Order article via Infotrieve]
• Kon V., Fogo A., Ichikawa I., Hellings SE et al. Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition. Kidney Int 1993;44:545-50.[Web of Science][Medline] [Order article via Infotrieve]
• AbeY., Miura K., Imanishi M. et al. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs. J Pharmacol Exp Ther 1980;214:166-70.[Abstract/Free Full Text]
• Miura K.,YukimuraT, Imanishi M. et al. Effect of SA-446, an angiotensin-converting enzyme inhibitor, on renal function in anesthetized dogs; special reference to arachidonic acid metabolites. J Cardiovasc Pharmacol 1985;7:102-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wong PC, Zimmerman BG, Kraft E. et al. Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril. J Pharmacol Exp Ther 1981; 219:646-50.[Abstract/Free Full Text]
• Wong PC, Zimmerman BG Mechanism of captopril(c)induced renal vasodilation in anesthetized dogs after nonhypotensive hemorrhage. N Pharmacol Exp Ther 1980;215:104-9.
• Oliver JA, Sciacca RR, Cannon PJ Renal vasodilation by converting enzyme inhibition: role of renal prostaglandins. Hypertension 1983;5:166-71.[Free Full Text]
• TobiaAJ, Giardino EC Renal vasodilator responses to captopril in dogs pre-treated with indomethacin (41157). Proc Soc Exp Biol Med 1981;167:242-7.[CrossRef][Medline] [Order article via Infotrieve]
• Fenoy FJ, Scicli G., Carretero O., Roman RJ Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril. Hypertension 1991;17:1038-44.[Abstract/Free Full Text]
• Johnston PA, Bernard DB, Perrin NS et al. Control of rat renal vascular resistance during alterations in sodium balance. Circ Res 1981;48:728-33.[Free Full Text]
• MimranA, Casellas D., Dupont M. Indirect evidence against a role of the kinin system in the renal hemodynamic effect of captopril in the rat. Kidney Int 1980;18:746-53.[Web of Science][Medline] [Order article via Infotrieve]
• Kimbrough HM, Vaughan ED, Carey RM et al. Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circ Res 1977;40:174-8.[Abstract/Free Full Text]
• Burger BM, Hopkins T., Tulloch A. et al. The role of angiotensin in the canine and vascular response to barbiturate anesthesia. Circ Res 1976;38:196-202.[Abstract/Free Full Text]
• Omoro SA, Majid DSA, Ed(c)Dahr SS et al. Kinin influences on renal regional blood flow responses to angiotensin-converting enzyme inhibition in dogs. Am J Physiol 1999;276:F271-F277.[Web of Science][Medline] [Order article via Infotrieve]
• Heller J., Kramer HJ, Horacek V. The effect of kinin and prostaglandin inhibitors on the renal response to angiotensin-converting enzyme inhibition: a micropuncture study in the dog. Pfugers Arch 1994;427:219-24.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Zimmerman BG, Goering JL, Raich PC Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium(c)restricted dog. Am J Physiol1988;255:F944-F952.
• Wong PY,Talamo RC, Williams GH et al. Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. J Clin Invest 1975;55:691-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mimran A., Guiod L., Hollenberg NK The role of angiotensin in the cardiovascular and renal response to salt restriction. Kidney Int 1974;5:348-55.[Web of Science][Medline] [Order article via Infotrieve]
• Hollenberg NK, Passan DR Specificity of renal vasodilation with captopril: saralasin prevents the response in the DOCA-treated, salt loaded rabbit. Life Sci 1982;31:329-34.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Chen K., Zimmerman BG Comparison of renal hemodynamic effect of ramiprilat to captopril; possible role of kinins. J Pharmacol Exp Ther 1994;270:491-7.[Abstract/Free Full Text]
• Toth-Heyn P., Mosig D., Guignard JP Role of bradykinin in the neonatal renal effects of angiotensin converting enzyme inhibition. Life Sci 1998;64:309-18.
• Tomoda F.,Lew RA, Smith Al et al. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits. Br J Pharmacol 1996;119:365-73.[Web of Science][Medline] [Order article via Infotrieve]
• Haij-Ali AF, Zimmerman BG Kinin contribution to renal vasodilator effect of captopril in rabbit. Hypertension 1991;17:504-9.[Abstract/Free Full Text]
• Swartz SL, Williams GH, Hollenberg NK et al. Captopril-induced changes in prostaglandin production: relationship tovascular responses in normal man. J Clin Invest 1980;65:1257-64.[Web of Science][Medline] [Order article via Infotrieve]
• Crantz FR, Swartz SL, Hollenberg NK et al. Role of prostaglandins in the hypotensive response to captopril in essential hypertension. Clin Res 1979;27:592.
• Hollenberg NK, Williams GH,Taub KJ et al. Renal vascular response to interruption of the renin-angiotensin system in normal man. Kidney Int 1977;12:285-93.[Web of Science][Medline] [Order article via Infotrieve]
• Hollenberg NK, Fisher NDL, Price DA Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system. Hypertension 1998;32:387-92.[Abstract/Free Full Text]
• Gainer JV, Morrow JD, Loveland A. et al. Effect of bradykinin-receptor blockade on the response to angiotensin-converting enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med1998;339:2285-92.

Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 2, 119-124 (2000)
DOI: 10.3317/jraas.2000.013


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lansang, M C. Articles by Hollenberg, N. K Search for Related Content PubMed PubMed Citation Articles by Lansang, M C. Articles by Hollenberg, N. K Social Bookmarking                         What's this?